Lyrica (pregabalin) most commonly causes dizziness and drowsiness, affecting roughly 30% and 23% of patients respectively in clinical trials. Beyond those two, the side effect profile includes dry mouth, swelling in the hands or feet, blurred vision, weight gain, and difficulty concentrating. Most of these effects are dose-dependent, meaning they tend to be milder at lower doses and more pronounced as the dose increases.
The Most Common Side Effects
In controlled trials involving adults, the side effects that showed up at least twice as often as placebo were dizziness, drowsiness, dry mouth, peripheral edema (swelling), blurred vision, weight gain, and trouble concentrating. Dizziness hit 30% of people taking Lyrica versus 8% on placebo. Drowsiness followed at 23% versus 8%. These two are by far the most frequently reported problems.
Blurred vision affected about 7% of Lyrica patients compared to 2% on placebo, and it resolved on its own in most cases even without stopping the medication. Swelling in the legs, ankles, or feet occurred in about 6% of patients versus 2% on placebo. Difficulty with concentration and attention rounds out the list, though exact percentages vary by the condition being treated.
Weight Gain
Weight gain is one of the side effects people notice most. In adult trials lasting up to 14 weeks, 9% of people on Lyrica gained 7% or more of their starting body weight, compared to 2% on placebo. In one study, about 22% of pregabalin patients gained at least 7% of their body weight while nobody in the placebo group did. A smaller subset, around 6%, gained between 10% and 15%. For someone who weighs 170 pounds, a 7% gain translates to roughly 12 pounds over a few months.
This effect doesn’t hit everyone, but if you’re already concerned about weight, it’s worth tracking early. The gain tends to be gradual rather than sudden.
Cognitive and Neurological Effects
About 35% of pregabalin users experience some form of neuropsychiatric side effect during treatment. The most common ones are dizziness, drowsiness, fatigue, and confusion. Many people describe these collectively as “brain fog,” a feeling that thinking is slower or less sharp than usual.
These effects are generally dose-dependent and mild to moderate. Reducing the dose often improves them. However, they don’t always go away on their own. In short-term trials, dizziness persisted through the entire course of treatment in 30% of the people who experienced it, and drowsiness persisted in 42%. So while some people adjust after the first week or two, a meaningful portion continue to feel these effects as long as they take the drug. Only about 4% of patients in post-marketing surveillance discontinued treatment because of side effects overall.
Swelling and Heart Health
The peripheral edema, or swelling, that Lyrica causes isn’t just cosmetic. Research into the mechanism found that it results from changes in blood vessel tone that cause fluid to leak into surrounding tissue. In a pharmacovigilance analysis, non-cardiogenic edema appeared at a median of 23 days after starting treatment and frequently occurred after a dose increase (60% of cases). The good news: swelling typically resolved within about a week of stopping the medication.
In rare cases, pregabalin has been associated with acute heart failure, with a median onset of 17 days. This is uncommon, but if you notice rapid, significant swelling alongside shortness of breath, that warrants immediate medical attention. People with existing heart conditions should be especially aware of this risk.
When Side Effects Start and How Long They Last
Most side effects begin shortly after starting Lyrica or increasing the dose. Dizziness and drowsiness typically appear within the first few days. Blurred vision tends to resolve on its own with continued use. Weight gain builds gradually over weeks to months rather than appearing overnight.
The timeline for resolution varies. Some effects, like blurred vision, improve even if you stay on the medication. Others, particularly drowsiness, can stick around for the entire duration of treatment. The 42% persistence rate for drowsiness means nearly half the people who feel it at the start are still dealing with it months later.
Serious but Less Common Risks
Lyrica carries a warning about increased risk of suicidal thoughts or behavior, a concern shared by all antiepileptic drugs. Pooled data from 199 placebo-controlled trials found that people taking antiepileptic drugs had roughly twice the risk of suicidal thinking compared to those on placebo. In absolute terms, this translated to about one additional case for every 530 patients treated. The risk appeared as early as one week after starting treatment and persisted throughout. This risk also applies after discontinuation.
Allergic reactions, while rare, have included angioedema, which involves swelling of the face, tongue, lips, and throat. Some cases were life-threatening and required emergency treatment. Skin reactions like hives, redness, and blisters have also been reported. These tend to appear shortly after starting the medication.
Stopping Lyrica Safely
Lyrica should not be stopped abruptly. Withdrawal effects are more likely if you’ve been taking it for longer than six weeks or at higher doses. The recommended approach is to taper gradually over a minimum of one week, with dose reductions happening no more frequently than once per week. Some people need more time between reductions to adjust, stretching the taper to every one or two weeks per step.
Newborns can also experience withdrawal symptoms if their mother takes pregabalin close to delivery, so extra monitoring may be needed for a few days after birth. Regarding fertility, current evidence does not show that pregabalin affects fertility in men or women. Some studies have suggested a slight increase in the risk of birth defects when taken during pregnancy, though findings are inconsistent.